CPC Scientific Inc

Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization (CRDMO) worldwide in terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production. We mainly provide (i) contract research organization (CRO) services, including peptide new chemical entity (NCE) discovery synthesis; (ii) contract development and manufacturing organization (CDMO) services, including peptide chemistry, manufacturing, and controls (CMC) development; and (iii) contract manufacturing organization (CMO) services, including peptide...

Contract development and manufacturing organization (cdmo),contract research organization (cro),fret and tr-fret substrates,cgmp peptide manufacturing,regulatory support,apis,custom peptides,catalog peptide,project management,generic peptides,cosmetic peptides,oligonucleotides,neoantigens,pepitde-oligonucleotide conjugates,peptide chelates,stapled pepitdes,peptide macrocycles,pegylation,us manufacturing,semaglutide,and tirzapetide

Cpc scientific inc operates in the Biotechnology research industry.

Cpc scientific inc's revenue is 11m - 100m

Cpc scientific inc has 11 - 50 employees.